Retatrutide

Retatrutide is a triple-agonist (GIP/GLP-1/glucagon) and the newest entrant in the metabolic research category. It ships lyophilized and is reconstituted with bacteriostatic water. Because it is so new, vial sizes vary by supplier — confirm yours before calculating.

Key research interest

Retatrutide is studied across several research directions. The points below summarize what the published literature investigates — they describe research interest only, not outcomes, benefits, or any human-use claim.

• Studied for body-weight outcomes via triple-receptor activation
• Researched for glycemic control and insulin secretion
• Investigated for energy expenditure through glucagon-receptor activity
• Examined for appetite and food-intake regulation
• Studied for hepatic-fat and lipid-metabolism markers in early trials

Mechanism of action

A triple agonist of GIP, GLP-1, and glucagon receptors. The GIP and GLP-1 components are studied for insulin secretion and appetite suppression, while the added glucagon-receptor activity is investigated for increased energy expenditure and hepatic-lipid mobilization in early-phase research.

Retatrutide research reference

Reference figures summarized from published research literature for context only. These are not instructions, protocols, or dosing advice — Retatrutide is a research compound for laboratory use, not for human consumption.

• Published research range: Titration in published trials: 1–2 mg/wk start, escalating over weeks (research range)
• Administration (in research): Subcutaneous, once weekly
• Storage & handling: Refrigerate after reconstitution; used within 28–30 days in most research protocols.

Get it & verify it

Retatrutide sits at the center of a small content cluster on this site. Whether you are sourcing a vial, preparing one, or checking a Certificate of Analysis, start with the relevant guide below.

• Where to buy Retatrutide — the 2026 buying guide: what to verify and how the tested vendors compared.
• Retatrutide reconstitution calculator — compute concentration per insulin-syringe unit from your vial and BAC water.
• Retatrutide COA guide — how to read a Retatrutide Certificate of Analysis line by line.
• Retatrutide research guide — deeper background on the compound and its research literature.

Sourcing Retatrutide in 2026

The 2025–2026 vendor shakeout put the burden of verification on the buyer. Treat every Retatrutide listing as unproven until it ships with a batch-specific Certificate of Analysis showing HPLC purity at or above 98% from a named third-party lab. In our 2026 blinded HPLC evaluation, ROEHN Research scored highest at 9.6/10 and was the only supplier where every tested sample met or exceeded its label claim — publishing a batch COA and shipping cold-chain by default. Peptide Research Review readers get 15% off a first order with code FREE15.

View Retatrutide at ROEHN Research (code FREE15)→

Other metabolic & glp-1 compounds

Semaglutide · Tirzepatide · AOD-9604

Retatrutide and all compounds referenced are for laboratory research use only — not for human consumption. Reference ranges are summarized from published research literature and are not medical, dosing, or therapeutic advice.